Evidence map›Paper›PMID 27903497›Full record

ArticleBMJ (Clinical research ed.)2016

Association between screening and the thyroid cancer "epidemic" in South Korea: evidence from a nationwide study.

Sohee Park, Chang-Mo Oh, Hyunsoon Cho, Joo Young Lee, Kyu-Won Jung, Jae Kwan Jun, Young-Joo Won, Hyun-Joo Kong, Kui Son Choi, You Jin Lee and 1 more

Abstract read
In one paragraph

Article in BMJ (Clinical research ed.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 130 papers, 8 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
130citing papers in PubMed, 8 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

130 citing papers in PubMed, 8 syntheses or guidelines pooled it.

  1. Pooled it
  2. Guideline
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Trial
  10. Trial
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

70 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Sohee ParkNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
Chang-Mo OhNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
Hyunsoon ChoNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
Joo Young LeeNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea jslee@ncc.re.kr.
Kyu-Won JungNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
Jae Kwan JunNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
Young-Joo WonNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
Hyun-Joo KongNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
Kui Son ChoiNational Cancer Control Institute, National Cancer Center, Goyang, Republic of Korea.
You Jin LeeCenter for Thyroid Cancer, National Cancer Center, Goyang, Republic of Korea jslee@ncc.re.kr.
Jin Soo LeeDepartment of Cancer Control and Policy, Graduate School of Cancer Science and Policy, National Cancer Center, Goyang, Republic of Korea jslee@ncc.re.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate whether screening for thyroid cancer led to the current "epidemic" in South Korea.

designReview of the medical records of nationally representative samples of patients with a diagnosis of thyroid cancer in 1999, 2005, and 2008.

settingSample cases were randomly selected from South Korea's nationwide cancer registry, using a systematic sampling method after stratification by region.

participants5796 patients with thyroid cancer were included (891 in 1999, 2355 in 2005, and 2550 in 2008).

main outcome measuresThe primary outcome was age standardised incidence of thyroid cancer and the changes in incidence between 1999 and 2008 according to the methods used to detect tumours (screen detection versus clinical detection versus unspecified).

resultsBetween 1999 and 2008, the incidence of thyroid cancer increased 6.4-fold (95% confidence interval 4.9-fold to 8.4-fold), from 6.4 (95% confidence interval 6.2 to 6.6) per 100 000 population to 40.7 (40.2 to 41.2) per 100 000 population. Of the increase, 94.4% (34.4 per 100 000 population) were for tumours less than 20 mm, which were detected mainly by screening. 97.1% of the total increase was localised and regional tumours according to the Surveillance, Epidemiology, and End Results (SEER) summary stage. Where cases were clinically detected, 99.9% of the increased incidences (6.4 per 100 000 population) over the same period were tumours less than 20 mm.

conclusionThe current "epidemic" of thyroid cancer in South Korea is due to an increase in the detection of small tumours, most likely as a result of overdetection. Concerted efforts are needed at a national level to reduce unnecessary thyroid ultrasound examinations in the asymptomatic general population.

Indexed as

Mass ScreeningCarcinomaFemaleHealth SurveysHumansIncidenceLymphatic MetastasisMaleMiddle AgedRegistriesRepublic of KoreaRetrospective StudiesThyroid Neoplasms

Identifiers

PMID27903497
PMCPMC5130923

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.